- Long-Term Survival of a Patient With Non–Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene
Nathaniel J. Myall et al, 2016, Clinical Lung Cancer CrossRef - High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer
Sören Weidemann et al, 2023, Applied Immunohistochemistry & Molecular Morphology CrossRef - BRAF p.V600E status in epithelial areas of ameloblastoma with different histological aspects: Implications to the clinical practice
Maria Sissa Pereira Sant’Ana et al, 2021, Journal of Oral Pathology & Medicine CrossRef - Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics
Jonathan L. Messerschmidt et al, 2017, Current Oncology Reports CrossRef - Is time to progression associated with post-progression survival in previously treated metastatic non-small cell lung cancer with BRAF V600E mutation? A secondary analysis of phase II clinical trial data
Junlong Li et al, 2018, BMJ Open CrossRef - Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment
Xiao-xiao Sun et al, 2015, Acta Pharmacologica Sinica CrossRef - Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small-Cell Lung Cancer: A Network Meta-Analysis
Junlong Li et al, 2018, Advances in Therapy CrossRef